Skip to content

Tuberculosis

Tuberculosis (TB) is a serious infectious disease caused by bacteria.  It is preventable and curable.

The goal of the Alaska Tuberculosis (TB) Program is the eventual elimination of TB from Alaska.

Take on TB Alaska. Too many people in Alaksa still suffer from tuberculosis (TB). 63 TB cases reported in the U.S. in 2018.

The Alaska TB Program:

  • provides medications for persons with active TB disease
  • helps to ensure that all persons with TB infection or disease are on appropriate regimens
  • assists with the monitoring and case management of persons on therapy for TB infection or disease
  • assists with the identification of persons exposed to TB
  • provides consultations to providers, public health nurses, and the public
  • provides TB education and outreach to partners throughout the state
Contact us:  (907) 269-8000 or tb@alaska.gov

Spotlight

CDC has new updated recommendations for a 12-dose regimen for latent TB infection for: Self-administration therapy, persons 2-11

NEW: Update on Recommendations for Use of Once-weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium Tuberculosis Infection (6/29/18). 

The updated recommendations, published in CDC’s Morbidity and Mortality Weekly Report (MMWR) support and expand the use of an effective, yet shorter treatment regimen to reach even more people with latent TB infection.

 

 Public Service Announcement

 
This film provides a history of tuberculosis infection, chemotherapy aides, and treatment in the region of Bethel, in southwestern Alaska. It serves to educate communities in the region and a call to action to continue screening efforts and get tested, as well as complete LTBI treatment to prevent further cases of active TB.


​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​